| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/22/2014 | US8703176 Hemostatic agent for topical and internal use |
| 04/22/2014 | US8703175 Compositions and methods for controlling drug loss and delivery in transdermal drug delivery systems |
| 04/22/2014 | US8703171 Method for easing human childbirth using a lubricant composition |
| 04/22/2014 | US8703164 Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof |
| 04/22/2014 | US8703159 Cosmetic composition containing polyglycerol partial ester |
| 04/22/2014 | US8703158 Theobromine for the treatment of cough |
| 04/22/2014 | US8703157 Phase transitioning hydrogels |
| 04/22/2014 | US8703155 Method of stabilizing reduced coenzyme q10 |
| 04/22/2014 | US8703111 Thermoplastic paste for repairing living tissues |
| 04/22/2014 | US8703105 Oleaginous pharmaceutical and cosmetic foam |
| 04/22/2014 | US8703104 Use of metal astringents for the treatment of hairy heel warts |
| 04/22/2014 | US8703095 Immuno-adjuvant emulsion |
| 04/22/2014 | US8702810 Bio-artificial pancreas and a procedure for preparation of same |
| 04/22/2014 | US8702685 Drug delivery system for treating erectile dysfunction |
| 04/22/2014 | US8702684 Therapeutic hybrid implantable devices |
| 04/22/2014 | US8702683 Systems and methods for dynamic drug therapy response to blood pressure incidents |
| 04/22/2014 | US8702682 Medical devices employing piezoelectric materials for delivery of therapeutic agents |
| 04/22/2014 | CA2830275A1 Omega 3-fatty acid emulsion |
| 04/22/2014 | CA2746985C Preparation method of polymeric micellar nanoparticles composition containing a poorly water-soluble drug |
| 04/22/2014 | CA2736633C Medication delivery system and monitor |
| 04/22/2014 | CA2653124C Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same |
| 04/22/2014 | CA2641570C Stabilization of solid thyroid drug formulations |
| 04/22/2014 | CA2631497C Emulsions of a protein-crosslinked hydrogel matrix and dispersed hydrophobic phase |
| 04/22/2014 | CA2630595C Foam wafer containing a polyvinyl alcohol-polyethyleneglycol-graft copolymer |
| 04/22/2014 | CA2618705C Improved delivery of tetrahydrocannabinol |
| 04/22/2014 | CA2611760C Oral dosage form comprising an antimisuse system |
| 04/22/2014 | CA2611451C Solid preparation |
| 04/22/2014 | CA2589489C Method of providing fast relief to a user of a nicotine chewing gum |
| 04/22/2014 | CA2585855C Dye-free pharmaceutical suspensions comprising sorbitol as a non-reducing sweetener and at least one active agent |
| 04/22/2014 | CA2572985C Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids |
| 04/22/2014 | CA2536430C Cosmetic emulsions with long-term stability |
| 04/22/2014 | CA2534897C Process of making flowable hemostatic compositions and devices containing such compositions |
| 04/22/2014 | CA2471657C Methods for improving the aesthetic appearance of skin |
| 04/17/2014 | WO2014059430A1 Delivery of small interfering rna and micro rna through membrane-disruptive, responsive nanoscalle hydrogels |
| 04/17/2014 | WO2014059385A1 Methods and small molecule therapeutics comprising fused elps |
| 04/17/2014 | WO2014059367A1 Pharmaceutical compositions containing enantiomerically pure and/or racemic mixtures of chiral piperazine compounds and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals through administration of said compositions |
| 04/17/2014 | WO2014059363A1 Oral solution formulations of aripiprazole |
| 04/17/2014 | WO2014059354A1 Pharmaceutical compositions containing piperazine compounds in combination with a p450 inhibitor and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals through administration of said compositions |
| 04/17/2014 | WO2014059309A1 Pharmaceutical formulations of pilocarpine |
| 04/17/2014 | WO2014059269A2 Multilayer compositions, coated devices and use thereof |
| 04/17/2014 | WO2014059262A1 Method of determining an injected dose based on a known oral dose |
| 04/17/2014 | WO2014059254A1 Topical ubiquinol oral supplement compositions with amorphous calcium phosphate |
| 04/17/2014 | WO2014059249A2 Remineralizing and desensitizing compositions, treatments and methods of manufacture |
| 04/17/2014 | WO2014059151A1 Method and device for reducing dermal filler adverse events |
| 04/17/2014 | WO2014059147A1 Methods and composition for treatment of th2-mediated and th17-mediated diseases |
| 04/17/2014 | WO2014059111A2 Method for increasing the oral bioavailability of a metabotropic glutamate 2/3 receptor antagonist |
| 04/17/2014 | WO2014059045A1 Natural coating formulas and composition for coating tablets |
| 04/17/2014 | WO2014059022A1 Nanoparticles for targeted delivery of multiple therapeutic agents and methods of use |
| 04/17/2014 | WO2014059009A1 Method of identifying synergistic cosmetic combinations |
| 04/17/2014 | WO2014058974A1 Methods of managing inflammation using glycolysis pathway inhibitors |
| 04/17/2014 | WO2014058605A1 Drug delivery capsules with external intelligence |
| 04/17/2014 | WO2014058559A1 Composition, system and method for tissue augmentation |
| 04/17/2014 | WO2014058427A1 Method and compositions for treating psoriasis |
| 04/17/2014 | WO2014058359A1 Method of coating and encapsulation of cells and cell aggregates with thick and stable polymer membrane |
| 04/17/2014 | WO2014058342A1 Calcium and magnesium biophosphate-based porous microspheres with controllable particle size for the regeneration of bone tissue |
| 04/17/2014 | WO2014058329A1 Compositions based on hypophyseal hormones for adding to infusion fluids |
| 04/17/2014 | WO2014058252A1 Ph-sensitive block copolymer containing cinnamaldehyde derivatives, and method for preparing same |
| 04/17/2014 | WO2014058188A1 Combination drug comprising gemigliptin and metformin, and method for the preparation thereof |
| 04/17/2014 | WO2014058179A2 Low-density lipoprotein analogue nanoparticles, and composition comprising same for targeted diagnosis and treatment of liver |
| 04/17/2014 | WO2014058079A1 Electrostatic-bonding-type vesicle including metal microparticles |
| 04/17/2014 | WO2014058047A1 Method for producing pharmaceutical preparation containing calcium antagonist/angiotensin ii receptor antagonist |
| 04/17/2014 | WO2014058046A1 Pharmaceutical preparation containing calcium antagonist/angiotensin ii receptor antagonist |
| 04/17/2014 | WO2014057966A1 Dialysis a agent comprising acetic acid and acetate, and two-part dialysis agent using same |
| 04/17/2014 | WO2014057928A1 Skin patch |
| 04/17/2014 | WO2014057499A1 A process for manufacturing sterile brinzolamide ophthalmic suspension |
| 04/17/2014 | WO2014057432A2 Multicomponent lipid nanoparticles and processes for the preparation thereof |
| 04/17/2014 | WO2014057365A1 Stable injectable pharmaceutical composition of epinephrine or salts thereof |
| 04/17/2014 | WO2014057351A1 Solid dosage form |
| 04/17/2014 | WO2014057203A1 Pharmaceutical compositions comprising capsules obtained by coacervation without the use of toxic cross-linking agents |
| 04/17/2014 | WO2014057202A1 Coacervation encapsulation method that does not involve the use of toxic cross-linking agents |
| 04/17/2014 | WO2014057096A1 Composition for alleviating conditions associated with vaginal dryness |
| 04/17/2014 | WO2014057092A1 Novel use of a composition comprising oxytocin |
| 04/17/2014 | WO2014057067A1 Cannabinoids for the treatment of cancers dependent on hedgehog mechanisms |
| 04/17/2014 | WO2014057059A1 Effervescent cefdinir formulation |
| 04/17/2014 | WO2014057043A1 Composition and delivery vehicle for active agents and methods therefor |
| 04/17/2014 | WO2014057038A1 Fast disintegrating solid dosage form formulation comprising functionalized calcium carbonate and method of their manufacture |
| 04/17/2014 | WO2014057026A1 Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate |
| 04/17/2014 | WO2014056942A1 Use of selectively moisture-adjusted tabletting material in the production of mechanically stable tablets which contain at least one hydrate-forming active substance and/or adjuvant relevant to the mechanical stability of the tablets, particularly arginine-containing tablets |
| 04/17/2014 | WO2014056939A1 Lipidic biomaterials for encapsulation and triggered release |
| 04/17/2014 | WO2014056882A1 Dosage forms containing terbutaline sulphate |
| 04/17/2014 | WO2014056779A1 Drug for the prophylaxis and treatment of a neurodegenerative disease |
| 04/17/2014 | WO2014056723A1 Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and on hydroxyapatite, for therapeutic use |
| 04/17/2014 | WO2014056722A2 Injectable sterile aqueous formulation based on crosslinked hyaluronic acid and hydroxyapatite for aesthetic use |
| 04/17/2014 | WO2014056413A1 Topical kidney and fertility reinforcing patch |
| 04/17/2014 | WO2014056280A1 Microencapsulated amino acid composition and preparation method thereof |
| 04/17/2014 | WO2014056070A1 (-)-deprenyl and related compounds for the treatment of alopecia |
| 04/17/2014 | WO2014036556A3 Drug delivery systems and methods for treatment of prostate disease comprising gemicitabine |
| 04/17/2014 | WO2014036528A3 Agents useful for treating obesity, diabetes and related disorders |
| 04/17/2014 | WO2014026656A8 Nanofiber structure with immobilized organic agens and the method of its preparation |
| 04/17/2014 | WO2014005103A3 Microparticle formulations for delivery to the lower and central respiratory tract and methods of manufacture |
| 04/17/2014 | WO2013109216A3 Preparation of dry powder formulations comprising tiotropium |
| 04/17/2014 | WO2012125567A3 Vaccine formulation of mannose coated peptide particles |
| 04/17/2014 | US20140107738 Magnetic particles |
| 04/17/2014 | US20140107594 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 04/17/2014 | US20140107560 Compositions for solubilizing cells and/or tissue |
| 04/17/2014 | US20140107423 System and Methods for Treating Ear Disorders |
| 04/17/2014 | US20140107227 Mucoadhesive drug delivery devices and methods of making and using thereof |
| 04/17/2014 | US20140107224 Generation of therapeutic microfoam |
| 04/17/2014 | US20140107195 Water-swellable polymers |
| 04/17/2014 | US20140107177 Methods and Compositions for Transdermal Delivery of Nucleotides |